Jonathan joined Amgen in 2018. He is currently a Scientist in the Cell Line Development group in Thousand Oaks, CA where he is advancing genome engineering capabilities to improve cell line performance for the production of Amgen’s biological therapeutics. Prior to Amgen, Jonathan completed an internship in the Cancer Immunology group at Genentech in South San Francisco, CA.

Featured Publications

Le K, Tan C, Le H, Tat J, Zasadzinska E, Diep J, Zastrow R, Chen C, Stevens J. (2019) Assuring clonality on the Beacon digital cell line development platform. Biotechnol J. doi: 10.1002/biot.201900247.
https://pubmed.ncbi.nlm.nih.gov/31743597/

Diep J*, Ooi YS*, Wilkinson AW*, Peters CE, Foy E, Johnson JR, Zengel J, Ding S, Weng KF, Laufman O, Jang G, Xu J, Young T, Verschueren E, Kobluk KJ, Elias JE, Sarnow P, Greenberg HB, Hüttenhain R, Nagamine CM, Andino R, Krogan NJ, Gozani O, Carette JE. (2019) Enterovirus pathogenesis requires the host methyltransferase SETD3. Nat Microbiol. doi: 10.1038/s41564-019-0551-1.
https://pubmed.ncbi.nlm.nih.gov/31527793/

Wilkinson AW*, Diep J*, Dai S, Liu S, Ooi YS, Song D, Li TM, Horton JR, Zhang X, Liu C, Trivedi DV, Ruppel KM, Vilches-Moure JG, Casey KM, Mark J, Cowan T, Elias JE, Nagamine CM, Spudich JA, Cheng X, Carette JE, Gozani O. (2019) SETD3 is an actin histidine methyltransferase that prevents primary dystocia. Nature. 565(7739):372-376.
https://pubmed.ncbi.nlm.nih.gov/30626964/

Pillay S, Meyer NL, Puschnik AS, Davulcu O, Diep J, Ishikawa Y, Jae LT, Wosen JE, Nagamine CM, Chapman MS, Carette JE. (2016) An essential receptor for adeno-associated virus infection. Nature. 530(7588):108-12.
https://pubmed.ncbi.nlm.nih.gov/26814968/

Education

Ph.D., Microbiology and Immunology, Stanford University
B.S., Microbiology Immunology and Molecular Genetics, University of California- Los Angeles